SARGENT BICKHAM LAGUDIS LLC – Eli Lilly and Company Transaction History
SARGENT BICKHAM LAGUDIS LLC portfolio value:
$3.53M
portfolio value
SARGENT BICKHAM LAGUDIS LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +9.57% | 954 shares | 300K | $323.35 | 10.91K |
Q2 2022 | share | Decrease | -9.72% | -1.07K shares | 70K | $324.23 | 9.96K |
Q1 2022 | share | Increase | +12.98% | 1.26K shares | 462K | $286.37 | 11.03K |
Q4 2021 | share | Increase | +715.53% | 8.57K shares | 2.42M | $277.25 | 9.77K |
Q3 2021 | share | Increase | +34.91% | 310 shares | 73K | $230.3 | 1.19K |
Q2 2021 | share | Increase | +16.38% | 125 shares | 61K | $228.04 | 888 |
Q1 2021 | share | Increase | +12.54% | 85 shares | 28K | $184.81 | 763 |
Q4 2020 | share | Increase | +2.57% | 17 shares | 17K | $166.32 | 678 |
Q3 2020 | share | 0.00% | 0 shares | -11K | $145.05 | 661 | |
Q2 2020 | share | 0.00% | 0 shares | 17K | $160.1 | 661 | |
Q1 2020 | share | Decrease | -24.89% | -219 shares | -24K | $134.64 | 661 |
Q4 2019 | share | Increase | +33.54% | 221 shares | 42K | $126.91 | 880 |
Q3 2019 | share | Increase | +35.32% | 172 shares | 20K | $107.36 | 659 |
Q2 2019 | share | Increase | +0.21% | 1 shares | -9K | $105.74 | 487 |
Q1 2019 | share | Decrease | -20.59% | -126 shares | -8K | $123.17 | 486 |
Q4 2018 | share | Decrease | -32.75% | -298 shares | -27K | $109.26 | 612 |
Q3 2018 | share | Increase | +0.22% | 2 shares | 20K | $100.8 | 910 |
Q2 2018 | share | Decrease | -14.02% | -148 shares | -4K | $79.72 | 908 |
Q1 2018 | share | Decrease | -20.06% | -265 shares | -30K | $71.78 | 1.05K |
Q4 2017 | share | Increase | +10.54% | 126 shares | 10K | $77.79 | 1.32K |
Q3 2017 | share | Increase | +102.20% | 604 shares | 53K | $78.29 | 1.19K |
Q2 2017 | share | Increase | +12.36% | 65 shares | 5K | $74.85 | 591 |
Q1 2017 | share | 0.00% | 0 shares | 5K | $76 | 526 | |
Q4 2016 | share | 0.00% | 0 shares | -3K | $66.02 | 526 | |
Q3 2016 | share | Decrease | -39.95% | -350 shares | -27K | $71.57 | 526 |
Q2 2016 | share | 0.00% | 0 shares | 6K | $69.79 | 876 | |
Q1 2016 | share | Increase | 0.00% | 876 shares | 63K | $63.39 | 876 |